$46.86
0.020.04%
At close: -
$46.91
0.050.11%
After Hours: 7:59 PM EDT
Comments
Loading...
Latest Bristol-Myers Squibb Stock News | NYSE:BMY | Benzinga
Get the latest news on Bristol-Myers Squibb stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Bristol-Myers Squibb performance
Categories: All
Monday, June 16, 2025
Thursday, June 12, 2025
Wednesday, June 11, 2025
Wednesday, June 04, 2025
Monday, June 02, 2025
Wednesday, May 28, 2025
Thursday, May 22, 2025
Tuesday, May 20, 2025
Friday, May 16, 2025
Wednesday, May 14, 2025
Tuesday, May 13, 2025
Monday, May 12, 2025
- EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients
- Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
- Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket
Thursday, May 08, 2025
Wednesday, May 07, 2025
Tuesday, May 06, 2025
Friday, May 02, 2025
Wednesday, April 30, 2025
Monday, April 28, 2025
Friday, April 25, 2025
Thursday, April 24, 2025
- Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results
- Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday?
- Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact
- Bristol-Myers Squibb Raises FY2025 Adj EPS Gu...
- Bristol-Myers Squibb Q1 Adj. EPS $1.80 Beats ...
- US Stock Futures Drop Amid Mixed Signals From White House On US-China Trade: 'Focus On Quality In A Diversified Manner,' Says Expert
- Earnings Scheduled For April 24, 2025
- PepsiCo, Alphabet And 3 Stocks To Watch Heading Into Thursday
- Dow Jumps Over 400 Points Amid China Tariff Hopes, Investor Fear Eases: Greed Index Remains In 'Fear' Zone
- Evotec Deepens CELMoDs Alliance With Bristol ...
Wednesday, April 23, 2025
- Cantor Fitzgerald Reiterates Neutral on Brist...
- Tesla To $303? Here Are 10 Top Analyst Forecasts For Wednesday
- Bristol Myers' Cobenfy Falls Short On Primary Endpoint In Phase 3 Schizophrenia Trial, Stock Slides
- Jefferies Maintains Buy on Bristol-Myers Squi...
- Bristol-Myers Squibb shares are trading lower...
